Stoke Therapeutics, Inc. · NASDAQ:STOK

Montrago Trustees Ltd reported a 6.00% stake in Stoke Therapeutics, Inc. (Schedule 13D/A)

Event Jun 18, 2025 · Filed Jun 23, 2025

Montrago Trustees Ltd reported a 6.00% stake in Stoke Therapeutics, Inc., 3,256,181 shares, with active intent on Jun 18, 2025. Filed Jun 23, 2025 (Schedule 13D/A).

Stake
6.00%
Shares
3,256,181
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Blue Horizon Enterprise Ltd5.40%2,967,621
Ezbon International Ltd0.50%288,560
Montrago Trustees Ltd6.00%3,256,181
Skorpios Trust6.00%3,256,181

Source

View original at SEC

Related